✦ LIBER ✦

Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23

✍ Scribed by Murat Kürtüncü; Erdem Tüzün; Recai Türkoğlu; Belgin Petek-Balcı; Sema İçöz; Münevver Pehlivan; Ömer Birişik; Canan Ulusoy; Erkingül Shugaiv; Gülşen Akman-Demir; Mefküre Eraksoy

Book ID: 116400667
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 243 KB
Volume: 59
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2012.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SHORT-TERM TREATMENT OF RELAPSING REMITT

SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α

✍ Ferdinando Nicoletti; Roberto Di Marco; Francesco Patti; Paola Zaccone; Maria Ri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Preliminary study: Treatment with intram

Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+and decreased levels of IL23R+CD4+T - Lymphocytes in multiple sclerosis

✍ Jennifer M Kress-Bennett; Garth D Ehrlich; Ashley Bruno; J Christopher Post; Fen 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 793 KB